Eric Joseph
Stock Analyst at Citi
(4.48)
# 1,067
Out of 4,456 analysts
326
Total ratings
53.1%
Success rate
11.9%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | n/a | $291.37 | - | 2 | Jun 26, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | $99 | $82.19 | +20.45% | 2 | Jun 16, 2026 | |
| PTCT PTC Therapeutics | Initiated Coverage: Buy | $67 → $108 | $84.43 | +27.92% | 31 | Jun 10, 2026 | |
| BBIO BridgeBio Pharma | Maintained: Hold | $82 | $70.24 | +16.74% | 3 | Jun 1, 2026 | |
| BMRN BioMarin Pharmaceutical | Maintained: Buy | $80 | $59.00 | +35.59% | 4 | May 20, 2026 | |
| IONS Ionis Pharmaceuticals | Initiated Coverage: Buy | $115 → $90 | $81.18 | +10.86% | 2 | May 20, 2026 | |
| ASND Ascendis Pharma | Initiated Coverage: Buy | $355 | $260.75 | +36.15% | 1 | May 15, 2026 | |
| TGTX TG Therapeutics | Maintained: Buy | $46 → $49 | $55.83 | -12.23% | 18 | Nov 3, 2025 | |
| PLRX Pliant Therapeutics | Downgraded: Sell | n/a | $1.14 | - | 7 | Oct 10, 2025 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $48 | $34.81 | n/a | 20 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $57 → $64 | $108.12 | n/a | 11 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $44 → $7 | $3.25 | n/a | 20 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $7 | $8.88 | n/a | 23 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.43 | n/a | 7 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $22 → $18 | $4.20 | n/a | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $37.34 | n/a | 3 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $21 → $11 | $18.56 | n/a | 12 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 | $10.03 | n/a | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1.53 | n/a | 1 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $12 | $22.29 | n/a | 10 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $21 | $5.83 | n/a | 5 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $71 → $70 | $182.08 | n/a | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $9 → $5 | $14.00 | n/a | 13 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $31 → $30 | $22.90 | n/a | 11 | Jan 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $11 | $1.32 | n/a | 11 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $7 | $4.26 | n/a | 6 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $10 | $3.52 | n/a | 6 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $15 → $5 | $11.61 | n/a | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $28 → $5 | $2.32 | n/a | 4 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $4.49 | n/a | 12 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $1.61 | n/a | 4 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $25.22 | n/a | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $10.21 | n/a | 8 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $13 | $4.13 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $5 | $5.57 | n/a | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $7 | $1.71 | n/a | 6 | Mar 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $1.14 | n/a | 5 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $11 | $7.29 | n/a | 3 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $8.67 | n/a | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $0.0001 | n/a | 3 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $39 → $26 | $34.54 | n/a | 3 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.86 | n/a | 1 | Feb 7, 2020 |
Alnylam Pharmaceuticals
Jun 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $291.37
Upside: -
Cytokinetics
Jun 16, 2026
Reiterated: Buy
Price Target: $99
Current: $82.19
Upside: +20.45%
PTC Therapeutics
Jun 10, 2026
Initiated Coverage: Buy
Price Target: $67 → $108
Current: $84.43
Upside: +27.92%
BridgeBio Pharma
Jun 1, 2026
Maintained: Hold
Price Target: $82
Current: $70.24
Upside: +16.74%
BioMarin Pharmaceutical
May 20, 2026
Maintained: Buy
Price Target: $80
Current: $59.00
Upside: +35.59%
Ionis Pharmaceuticals
May 20, 2026
Initiated Coverage: Buy
Price Target: $115 → $90
Current: $81.18
Upside: +10.86%
Ascendis Pharma
May 15, 2026
Initiated Coverage: Buy
Price Target: $355
Current: $260.75
Upside: +36.15%
TG Therapeutics
Nov 3, 2025
Maintained: Buy
Price Target: $46 → $49
Current: $55.83
Upside: -12.23%
Pliant Therapeutics
Oct 10, 2025
Downgraded: Sell
Price Target: n/a
Current: $1.14
Upside: -
Beam Therapeutics
Jun 25, 2025
Reiterated: Buy
Price Target: $48
Current: $34.81
Upside: n/a
Jun 2, 2025
Reiterated: Buy
Price Target: $57 → $64
Current: $108.12
Upside: n/a
May 28, 2025
Downgraded: Hold
Price Target: $44 → $7
Current: $3.25
Upside: n/a
May 19, 2025
Reiterated: Sell
Price Target: $7
Current: $8.88
Upside: n/a
May 19, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.43
Upside: n/a
May 16, 2025
Maintained: Buy
Price Target: $22 → $18
Current: $4.20
Upside: n/a
May 14, 2025
Maintained: Buy
Price Target: n/a
Current: $37.34
Upside: n/a
May 13, 2025
Maintained: Buy
Price Target: $21 → $11
Current: $18.56
Upside: n/a
May 7, 2025
Maintained: Hold
Price Target: $14
Current: $10.03
Upside: n/a
Apr 25, 2025
Initiated Coverage: Hold
Price Target: n/a
Current: $1.53
Upside: n/a
Mar 20, 2025
Maintained: Buy
Price Target: $15 → $12
Current: $22.29
Upside: n/a
Mar 4, 2025
Maintained: Buy
Price Target: $20 → $21
Current: $5.83
Upside: n/a
Feb 27, 2025
Maintained: Buy
Price Target: $71 → $70
Current: $182.08
Upside: n/a
Feb 10, 2025
Maintained: Sell
Price Target: $9 → $5
Current: $14.00
Upside: n/a
Jan 29, 2025
Maintained: Buy
Price Target: $31 → $30
Current: $22.90
Upside: n/a
Dec 17, 2024
Reiterated: Hold
Price Target: $11
Current: $1.32
Upside: n/a
Feb 23, 2024
Maintained: Hold
Price Target: $6 → $7
Current: $4.26
Upside: n/a
Nov 13, 2023
Maintained: Hold
Price Target: $11 → $10
Current: $3.52
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $15 → $5
Current: $11.61
Upside: n/a
Aug 28, 2023
Downgraded: Hold
Price Target: $28 → $5
Current: $2.32
Upside: n/a
Aug 10, 2023
Downgraded: Sell
Price Target: n/a
Current: $4.49
Upside: n/a
May 5, 2023
Maintained: Hold
Price Target: $6 → $5
Current: $1.61
Upside: n/a
Nov 29, 2022
Downgraded: Sell
Price Target: n/a
Current: $25.22
Upside: n/a
Nov 4, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $10.21
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $12 → $13
Current: $4.13
Upside: n/a
May 5, 2022
Maintained: Hold
Price Target: $6 → $5
Current: $5.57
Upside: n/a
Mar 29, 2022
Maintained: Buy
Price Target: $24 → $7
Current: $1.71
Upside: n/a
Mar 4, 2022
Maintained: Sell
Price Target: n/a
Current: $1.14
Upside: n/a
Nov 11, 2021
Maintained: Hold
Price Target: $14 → $11
Current: $7.29
Upside: n/a
Oct 8, 2021
Downgraded: Sell
Price Target: n/a
Current: $8.67
Upside: n/a
Nov 9, 2020
Downgraded: Sell
Price Target: n/a
Current: $0.0001
Upside: n/a
Sep 21, 2020
Maintained: Hold
Price Target: $39 → $26
Current: $34.54
Upside: n/a
Feb 7, 2020
Reiterated: Hold
Price Target: n/a
Current: $5.86
Upside: n/a